The associations between ras mutations and clinical characteristics in follicular thyroid tumors: New insights from a single center and a large patient cohort

Thyroid

Volumn 22, Issue 7, 2012, Pages 683-689

  Fukahori, Michiko ^a   Yoshida, Akira ^a   Hayashi, Hiroyuki ^a   Yoshihara, Mitsuyo ^a   Matsukuma, Shoichi ^a   Sakuma, Yuji ^a   Koizume, Shiro ^a   Okamoto, Naoyuki ^a   Kondo, Tetsuo ^b   Masuda, Munetake ^c   Miyagi, Yohei ^a  

^a KANAGAWA CANCER CENTER   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CODON; DISEASE COURSE; DISTANT METASTASIS; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; MUTATIONAL ANALYSIS; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE RAS; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 84863500976     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0261     Document Type: Article

References (21)

1. Grebe SK, Hay ID 1995 Follicular thyroid cancer. Endocrinol Metab Clin North Am 24:761-801.
2. DeLellis RA 2006 Pathology and genetics of thyroid carcinoma. J Surg Oncol 94:662-669.
3. D?Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH 2004 Follicular thyroid carcinoma: Histology and prognosis. Cancer 100:1123-1129.
4. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW II, Tallini G, Kroll TG, Nikiforov YE 2003 RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: Evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326.
5. Lin JD, Chao TC 2006 Follicular thyroid carcinoma: From diagnosis to treatment. Endocr J 53:441-448.
6. DeLellis RA, Lloyd RV, Heitz PU, Eng C 2004 World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon, pp 67-72.
7. Besic N, Zgajnar J, Hocevar M, Frkovic-Grazio S 2005 Is patient?s age a prognostic factor for follicular carcinoma in the TNM classification system? Thyroid 15:439-448.
8. Rao RS, Parikh HK, Deshmane VH, Parikh DM, Shrikhande SS, Havaldar R 1996 Prognostic factors in follicular carcinoma of the thyroid: A study of 198 cases. Head Neck 18:118-126.
9. Shaha AR, Loree TR, Shah JP 1995 Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131-1138.
10. Vasko V, Ferrand M, Di Cristofaro J, Carayon P, Henry JF, De Micco C 2003 Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab 88: 2745-2752.
11. Manenti G, Pilotti S, Re FC, Della Porta G, Pierotti MA 1994 Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Eur J Cancer 30A:987-993.
12. Salvatore D, Celetti A, Fabien N, Paulin C, Martelli ML, Battaglia C, Califano D, Monaco C, Viglietto G, Santoro M, Fusco A 1996 Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fiftysix thyroid tumours. Eur J Endocrinol 134:177-183.
13. Garcia-Rostan G, Zhao H, Camp RL, Pollan M, Herrero A, Pardo J, Wu R, Carcangiu ML, Costa J, Tallini G 2003 ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol 21:3226-3235.
14. Basolo F, Pisaturo F, Pollina LE, Fontanini G, Elisei R, Molinaro E, Iacconi P, Miccoli P, Pacini F 2000 N-ras mutation in poorly differentiated thyroid carcinomas: Correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid 10:19-23.
15. Volante M, Rapa I, Gandhi M, Bussolati G, Giachino D, Papotti M, Nikiforov YE 2009 RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 94:4735-4741.
16. Matsukuma S, Yoshihara M, Kasai F, Kato A, Yoshida A, Akaike M, Kobayashi O, Nakayama H, Sakuma Y, Yoshida T, Kameda Y, Tsuchiya E, Miyagi Y 2006 Rapid and simple detection of hot spot mutations of epidermal growth factor receptor, BRAF, and NRAS in cancers using the loop-hybrid mobility shift assay. J Mol Diagn 8:504-512.
17. Nikiforova MN, Nikiforov YE 2008 Molecular genetics of thyroid cancer: Implications for daiagnosis, treatment and prognosis. Expert Rev Mol Diagn 8:83-95.
18. Kroll TG 2004 Molecular events in follicular thyroid tumors. Cancer Treat Res 122:85-105.
19. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Katsuragi K, Kinoshita M, Saito S, Itakura M 1992 Ras mutations in endocrine tumors: Mutation detection by polymerase chain reaction-single strand conformation polymorphism. Jpn J Cancer Res 83:1057-1062.
20. Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW, Harris PE 1999 Prevalence of ras mutations in thyroid neoplasia. Clin Endocrinol (Oxf) 50:529-535.
21. Liu RT, Hou CY, You HL, Huang CC, Hock-Liew, Chou FF, Wang PW, Cheng JT 2004 Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan. Thyroid 14:616-621.